Under the hood: The molecular biology driving gene therapy for the treatment of sickle cell disease

Waldron, E., & Tanhehco, Y. C. (2022). Under the hood: The molecular biology driving gene therapy for the treatment of sickle cell disease. Transfusion and Apheresis Science, 61(5), 103566. https://doi.org/10.1016/j.transci.2022.103566
Authors:
Evan Waldron
Yvette C. Tanhehco
Affiliated Authors:
Evan Waldron
Yvette C. Tanhehco
Columbia Affiliation:
Subjects:
Anemia, Sickle Cell (MeSH)
Author Keywords:
hematopoietic stem cell transplantation
gene therapy
sickle cell disease
crispr-cas9
lentiglobin
rna interference
elink
Publication Type:
Article
Unique ID:
10.1016/j.transci.2022.103566
PMID:
36115765
DOI:
10.1016/j.transci.2022.103566
Journal:
Transfusion and Apheresis Science
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record

Record Created: